ARTICLE | Clinical News
Hydroxyurea capsules regulatory update
January 30, 2006 8:00 AM UTC
BMY issued a "Dear Healthcare Provider" letter for hydroxyurea capsules to warn about cutaneous vascular toxicites, including vasculitic ulcerations and gangrene, in patients with myeloproliferative d...